Highlights
Both high dose and low dose TSEBT achieve high response rates.
No statiscal difference between two dose regimens was found in this study.
We propose to use low dose TSEBT in all patients with boost to residual disease if indicated.
High dose regimens should be reserved for patients where it is not feasible to boost too many lesions.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.